Clinical Trial Update: Study to Evaluate the Cardiac Safety of TAS-102 in Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 study evaluating cardiac safety of TAS-102 in patients with advanced solid tumors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• TAS-102 (trifluridine/tipiracil)

Snippet

Sponsor: Taiho Oncology, Inc. | Conditions: Advanced Solid Tumors (Excluding Breast Cancer) | Phase 1 | Status: COMPLETED